IMPROVEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the field of biopharmaceuticals, presenting promising advancements across many healthcare and industrial programs. With its structural similarity to The natural way derived human serum albumin, OsrHSA provides a safer, far more trustworthy choice for therapeutic use